Interventions to induce lasting HIV remission are needed to obviate the requirement for lifelong antiretroviral therapy (ART). Durable post-intervention control (PIC) of viremia has been achieved in a subset of individuals following broadly neutralizing anti-HIV-1 antibody (bNAb) administration and analytical treatment interruption (ATI)^1-4. Prior studies support a role for CD8⁺T cells^5-9but the precise features of CD8⁺T cells involved in PIC remain unclear. Here we mapped and functionally profiled CD8⁺T cell responses to autologous HIV epitopes using longitudinal samples from four ATI trials in bNAb recipients. PIC was associated with superior pre-intervention HIV-specific CD8⁺T cell proliferative capacity, stem cell-like memory phenotype, and recall cytotoxicity against autologous HIV peptide-pulsed CD4⁺T cells. CD8⁺T cell stemness was further increased following bNAb administration without emergence of new clonotypes targeting defined HLA-optimal epitopes. Multimodal single-cell analyses revealed molecular features associated with PIC and HIV-specific CD8⁺T cell stemness, including signatures of metabolic fitness and reduced T cell exhaustion. These results identify immune features that precede subsequent PIC to inform the development of combination immunotherapies that will elicit durable HIV remission.

<

p style=”font-size:18px;color:#555″>
Disclaimer: This news article has been republished exactly as it appeared on its original source, without any modification.
We do not take any responsibility for its content, which remains solely the responsibility of the original publisher.

Author:Zahra Kiani
Published on:2025-12-01 04:00:00
Source: www.nature.com

uaetodaynews

UAETodayNews delivers the latest news and updates from the UAE, Arab world, and beyond. Covering politics, business, sports, technology, and culture with trusted reporting.